Class II
Terminated
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
This recall has been terminated (originally issued November 23, 2022).
- Company
- Imprimisrx Nj
- Recall Initiated
- November 9, 2022
- Posted
- November 23, 2022
- Recall Number
- D-0060-2023
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 960 bottles
- Firm Location
- Ledgewood, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Distribution
Nationwide in the USA
Lot / Code Info
Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023
More recalls by Imprimisrx Nj
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026